Efficacy of continuous hemodiafiltration with a cytokine-adsorbing hemofilter in the treatment of acute respiratory distress syndrome

Contributions to Nephrology

Volumn 166, Issue , 2010, Pages 83-92

  Matsuda, Kenichi ^a   Moriguchi, Takeshi ^a   Oda, Shigeto ^b   Hirasawa, Hiroyuki ^b  

^a UNIVERSITY OF YAMANASHI   (Japan)

^b CHIBA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; INTERLEUKIN 6; INTERLEUKIN 8; POLY(METHYL METHACRYLATE); TUMOR NECROSIS FACTOR ALPHA;

ADULT RESPIRATORY DISTRESS SYNDROME; ARTICLE; ARTIFICIAL MEMBRANE; BLOOD; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; HEMODIAFILTRATION; HUMAN; IMMUNOMODULATION; ISOLATION AND PURIFICATION; KIDNEY FAILURE; METHODOLOGY; SURVIVAL RATE;

CYTOKINES; HEMODIAFILTRATION; HUMANS; IMMUNOMODULATION; INTERLEUKIN-6; INTERLEUKIN-8; KIDNEY FAILURE; MEMBRANES, ARTIFICIAL; POLYMETHYL METHACRYLATE; RESPIRATORY DISTRESS SYNDROME, ADULT; SURVIVAL RATE; TUMOR NECROSIS FACTOR-ALPHA;

EID: 77955885699     PISSN: 03025144     EISSN: None     Source Type: Book Series    
DOI: 10.1159/000314856     Document Type: Article

References (20)

1. Wheeler A P, Bernard GR: Acute lung injury and the acute respiratory distress syndrome: a clinical review. Lancet 2007;369:1553-156
2. Maniatis NA, Kotanidou A, Catravas JD, Orfanos SE: Endothelial pathomechanisms in acute lung injury. Vascul Pharmacol 2008 49:119-133.
3. Hemmila MR, Napolitano LM: Severe respiratory failure: advanced treatment options. Crit Care Med 2006;34(suppl): S278-S290.
4. Raghavendran K, Pryhuber GS, Chess PR, Davidson BA, Knight PR, Notter RH: Pharmacotherapy of acute lung injury and acute respiratory distress syndrome. Curr Med Chem 2008;15:1911-1924.
5. Antonelli M, Azoulay E, Bonten M, Chastre J, Citerio G, Conti G, De Backer D, Lemaire F, Gerlach H, Groeneveld J, Hedenstierna G, Macrae D, Mancebo J, Maggiore SM, Mebazaa A, Metnitz P, Pugin J, Wernerman J, Zhang H: Year in review in Intensive Care Medicine, 2008. II. Experimental, acute respiratory failure and ARDS, mechanical ventilation and endotracheal intubation. Intensive Care Med 2009;35:215-231.
6. Zambon M, Vincent JL: Mortality rates for patients with acute lung injury/ARDS have decreased over time. Chest 2008;133:1120-1127.
7. Phua J, Badia JR, Adhikari NK, Friedrich JO, Fowler RA, Singh JM, Scales DC, Stather DR, Li A, Jones A, Gattas DJ, Hallett D, Tomlinson G, Stewart TE, Ferguson ND: Has mortality from acute respiratory distress syndrome decreased over time? A systematic review. Am J Respir Crit Care Med 2009;179:220-227.
8. Matsuda K, Hirasawa H, Oda S, Shiga H, Nakanishi K: Current topics on cytokine removal technologies. Ther Apher 2001;5:306-314.
9. Nakada T, Hirasawa H, Oda S, Shiga H, Matsuda K: Blood purification for hypercytokinemia. Transfus Apher Sci 2006;35:253-264.
10. Hirasawa H, Oda S, Matsuda K: Continuous hemodiafiltration with cytokine-adsorbing hemofilter in the treatment of severe sepsis and septic shock. Contrib Nephrol 2007;156:365-370.
11. Nakada T, Oda S, Matsuda K, Sadahiro T, Nakamura M, Abe R, Hirasawa H: Continuous hemodiafiltration with PMMA hemofilter in the treatment of patients with septic shock. Mol Med 2008;14:257-263.
12. Hirasawa H, Sugai T, Oda S, Shiga H, Matsuda K, Ueno H, Sadahiro T, Hikita S: Continuous hemodiafiltration (CHDF) removes cytokines and improves respiratory index (RI) and oxygen metabolism in patients with acute respiratory distress syndrome (ARDS). Crit Care Med 1998;26(suppl): A120.
13. Ohtake Y, Hirasawa H, Sugai T, Oda S, Shiga H, Matsuda K, Kitamura N: Nafamostat mesylate as anticoagulant in continuous hemofiltration and continuous hemodiafiltration. Contrib Nephrol 1991;93:215-217.
14. Schetz M: Non-renal indications for continuous renal replacement therapy. Kidney Int 1999;72: S88-S94.
15. Zimmerman JL: Respiratory failure. Blood Purif 2002;20:235-238.
16. DiCarlo J V, Alexander SR, Agarwal R, Schiffman JD: Continuous veno-venous hemofiltration may improve survival from acute respiratory distress syndrome after bone marrow transplantation or chemotherapy. J Pediatr Hematol Oncol 2003;25:801-805.
17. Piccinni P, Dan M, Barbacini S, Carraro R, Lieta E, Marafon S, Zamperetti N, Brendolan A, D'Intini V, Tetta C, Bellomo R, Ronco C: Early isovolaemic haemofiltration in oliguric patients with septic shock. Intensive Care Med 2006;32:80-86.
18. Ronco C: Renal replacement therapy for acute kidney injury: let's follow the evidence. Int J Artif Organs 2007;30:89-94.
19. House AA, Ronco C: Extracorporeal blood purification in sepsis and sepsis-related acute kidney injury. Blood Purif 2008;26:30-35.
20. Hirayama Y, Hirasawa H, Oda S, Shiga H, Nakanishi K, Matsuda K, Nakamura M, Hirano T, Moriguchi T, Watanabe E, Nitta M, Abe R, Nakada T: The change in renal replacement therapy on acute renal failure in a general ICU in a university hospital and its clinical efficacy: a Japanese experience. Ther Apher Dial 2003;7:475-482.